reduced-infant-opioid-withdrawal-severity-associated-with-care-model-expansion
Reduced Infant Opioid Withdrawal Severity Associated With Care Model Expansion

Reduced Infant Opioid Withdrawal Severity Associated With Care Model Expansion

A recent mixed-methods evaluation of the Managing Abstinence in Newborns (MAiN) 2.0 model has revealed that implementing standardized, family-centered care practices across rural hospitals can lead to significant improvements in clinical outcomes for infants exposed to opioids prenatally. As the United States continues to face rising rates of neonatal opioid withdrawal syndrome (NOWS), healthcare systems are increasingly adopting nonpharmacologic approaches designed to reduce the severity of symptoms and improve maternal-infant engagement. The study, which focused on the midpoint implementation of the MAiN 2.0 program at four hospitals in South Carolina, found measurable declines in symptom severity and notable increases in maternal participation throughout the recovery process. These results suggest that translating evidence-based protocols into diverse clinical settings is feasible and effective, though successful adoption depends heavily on local hospital resources and ongoing support systems.

The MAiN 2.0 program was developed in response to a 16.5% increase in NOWS cases in South Carolina between 2016 and 2020. The original MAiN model, which emphasizes standardized clinical protocols, interdisciplinary coordination, and nonpharmacologic care, was scaled to 10 expansion hospitals. To evaluate the program’s progress, researchers used a convergent mixed-methods design, incorporating both quantitative clinical data and qualitative insights from key hospital stakeholders. The baseline data for the evaluation were collected retrospectively from the 12 months preceding the model’s implementation at these sites, while midpoint data were gathered prospectively once hospitals achieved an initial implementation threshold. By comparing these two time periods, the research team aimed to identify changes in maternal and infant outcomes and better understand the practical barriers and facilitators influencing the model’s adoption.

The study cohort included 68 opioid-exposed mother-infant dyads, with 39 cases originating from the baseline period and 29 from the implementation midpoint. The participating hospitals were selected based on the availability of consistent clinical data at both time points rather than specific performance metrics or implementation success. Throughout the study, the research team employed independent-samples t-tests and chi-square tests to analyze clinical data, including NOWS severity measured by the modified Finnegan Neonatal Abstinence Scoring (FNAS) tool. Qualitative data were collected through semi-structured interviews with 23 key informants, including nurses, pediatricians, administrators, and therapists, whose insights were analyzed using the Consolidated Framework for Implementation Research (CFIR) to provide a comprehensive look at the program’s real-world application.

The quantitative results demonstrated clear improvements in infant and maternal health metrics. Peak NOWS scores among infants in the midpoint cohort were significantly lower than those at baseline, with a median score of 8.0 compared to 13.0, indicating a meaningful reduction in symptom severity. Furthermore, infants were far more likely to be discharged directly into their mothers’ care during the midpoint period, rising from 17.2% at baseline to 75.9%. Monitoring practices also became more consistent, with 70.8% of infants monitored throughout their hospital stay in the midpoint cohort compared to only 24.0% at baseline. While some metrics, such as the length of hospital stay and the timing of peak symptoms, did not show statistically significant differences, the overall trends pointed toward a more cohesive and responsive approach to managing opioid exposure.

Maternal engagement also saw a substantial shift during the implementation period. Women in the midpoint cohort attended a median of 10 prenatal visits, a significant increase from the median of 5 visits during the baseline period. This improved engagement was mirrored in hospital practices; rooming-in duration more than doubled, increasing from 2.7 days at baseline to 5.5 days at the midpoint, reflecting a deep shift toward family-centered care. Additionally, the study noted a significant rise in the completion of lactation consultations, which increased from 14.8% to 60.8%.

Qualitative findings gathered from the 23 key informants helped bridge the gap between these statistical improvements and the lived experience of implementing the MAiN 2.0 model. Stakeholders consistently identified staff training and professional development as the primary facilitators of the program’s success. By providing clinical teams with standardized education, the MAiN 2.0 model effectively increased provider confidence and reduced clinical variation. Furthermore, the presence of engaged hospital leadership and dedicated site champions was cited as a major factor in improving staff buy-in and fostering a supportive cultural environment that actively worked to reduce the stigma historically associated with prenatal opioid use and NOWS.

Despite the observed progress, the evaluation highlighted persistent barriers that limited the scope and consistency of implementation. The most frequently mentioned challenges included workforce constraints, such as staff shortages and high turnover, which strained hospital resources and hindered training initiatives. Pharmacy-related hurdles, such as difficulties in medication dispensing and a lack of standardized protocols, also emerged as significant impediments to workflow efficiency. Additionally, participants identified gaps in communication across different hospital departments and noted that broader social determinants—such as a lack of access to community social work resources and difficulties in engaging mothers who may face complex structural constraints—remained substantial challenges throughout the implementation process.

The integration of quantitative and qualitative data suggests that the improvements in infant outcomes were directly associated with the increased adoption of the standardized practices encouraged by the MAiN 2.0 model. When hospital staff felt supported by leadership and equipped with proper training, they were better able to implement rooming-in and breastfeeding support, which in turn contributed to the observed reduction in NOWS severity. Conversely, the persistence of structural barriers like staffing instability explains why certain outcomes, such as total length of stay, remained relatively unchanged despite the implementation of new protocols. These findings confirm that while a clinical model can provide a framework for care, the effectiveness of that model is intrinsically tied to the local infrastructure and the availability of system-level support.

The researchers noted several limitations to the study, particularly regarding its scope and generalizability. The voluntary participation of hospitals within a single state means the findings may not be fully representative of hospitals in other regions with different resources or populations. Additionally, the reliance on data from only four of the ten expansion hospitals introduces the potential for selection bias, as the study only included sites with the most complete records. The researchers also pointed out that the lack of a concurrent control group makes it difficult to isolate the effects of the MAiN 2.0 program from other external factors, such as broader changes in national care standards or regional health initiatives implemented during the same timeframe. Future evaluations will need to account for these variables as they look toward longer-term program sustainability.

Ultimately, the midpoint evaluation of the MAiN 2.0 model provides compelling evidence that structured, evidence-based care can improve the management of neonatal opioid withdrawal syndrome. By shifting the focus toward prenatal engagement, standardized family-centered care, and provider education, hospitals can achieve meaningful reductions in symptom severity and improve the quality of care for vulnerable mother-infant dyads. As healthcare systems look to scale these initiatives, the results emphasize the necessity of ongoing investment in interdisciplinary coordination and structural capacity. Future research must now address whether these early successes can be maintained over time and how institutions can best mitigate the persistent resource limitations that continue to challenge the equitable delivery of care across diverse medical settings.

Subject of Research: Evaluating the implementation of the MAiN 2.0 model for neonatal opioid withdrawal syndrome care in rural hospitals.

Article Title: Expanding evidence-based care for opioid-exposed mother-infant dyads: a mixed-methods study

Article References: Mayo, R. M., Sutton, J. C., Edgar, M., Dickes, L., Sherrill, W. W., Holcomb, L. A., Charron, E., Treado, B., Howle, K., Boyd, J., & Hudson, J. (2026). Expanding evidence-based care for opioid-exposed mother-infant dyads: a mixed-methods study. Maternal Health, Neonatology and Perinatology, 12(1), Article 44. https://doi.org/10.1186/s40748-026-00290-7

Image Credits: AI Generated

DOI: 10.1186/s40748-026-00290-7

Keywords: Neonatal Opioid Withdrawal Syndrome, NOWS, MAiN 2.0, opioid exposure, family-centered care, maternal health, neonatal health, perinatal care, clinical outcomes, implementation science, mixed-methods study, South Carolina, prenatal care, lactation support, rooming-in, hospital administration